Article
The superoxide dismutase mimetic GC4419 enhances tumor killing when combined with stereotactic ablative radiation
2020-03-11
Abstract excerpt
The penta-aza macrocyclic manganese compound GC4419 is in phase 3 clinical trials as a modifier of mucositis in H&N cancer treated by radio-chemotherapy based upon its properties as a superoxide dismutase mimetic. In studies to address the potential for tumor radioprotection, a significant anti-tumor effect was identified in tumors generated from the non-small cell lung cancer (NSCLC) cell line H1299, when GC4419...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ad2b39b8-143a-5139-93e3-8c5513f9d928
- DOI
- 10.1101/2020.03.10.984443
